SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $36,383,000 | +5.5% | 3,850,000 | 0.0% | 0.50% | +3.1% |
| Q2 2020 | $34,496,000 | +40.7% | 3,850,000 | 0.0% | 0.49% | +2.5% |
| Q1 2020 | $24,525,000 | -23.9% | 3,850,000 | 0.0% | 0.48% | -6.8% |
| Q4 2019 | $32,225,000 | -2.4% | 3,850,000 | +5.5% | 0.51% | -16.8% |
| Q3 2019 | $33,033,000 | -16.0% | 3,650,000 | 0.0% | 0.61% | -8.5% |
| Q2 2019 | $39,311,000 | – | 3,650,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |